
Rovertis Pharmaceuticals Private Limited
Founded in 2004 and headquartered in Telangana, India.
Founded in 2004 and headquartered in Telangana, India.
Rovertis Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 October 2004 and has a history of 20 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.96 M, as per Ministry of Corporate Affairs (MCA) records.
Swarna Pagadala, Rajitha Rajaboina, Padma Rajaboina, and Three other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
-
U24239TG2004PTC044325
044325
Private Limited Indian Non-Government Company
04 Oct 2004
30 Sep 2024
31 Mar 2024
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Swarna Pagadala ![]() | Director | 04-Oct-2004 | Current |
Rajitha Rajaboina ![]() | Director | 20-Dec-2010 | Current |
Padma Rajaboina ![]() | Director | 04-Oct-2004 | Current |
Krishnam Vegesna ![]() | Director | 04-Oct-2004 | Current |
Sreenivasa Devarakonda ![]() | Director | 20-Dec-2010 | Current |
Swarupa Chintala ![]() | Director | 04-Oct-2004 | Current |
Rovertis Pharmaceuticals Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 5.75% decrease. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 7.78%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth |
| ||||||
EBITDA |
|
In 2016, Rovertis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Swarupa Chintala is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rovertis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rovertis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rovertis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rovertis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Rovertis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Rajitha Rajaboina was appointed as a Director was appointed as a Director on 20 Dec 2010 & has been associated with this company since 14 years 2 months .
Sreenivasa Rao Devarakonda was appointed as a Director was appointed as a Director on 20 Dec 2010 & has been associated with this company since 14 years 2 months .
Swarna Latha Pagadala was appointed as a Director was appointed as a Director on 04 Oct 2004 & has been associated with this company since 20 years 4 months .
Padma Rajaboina was appointed as a Director was appointed as a Director on 04 Oct 2004 & has been associated with this company since 20 years 4 months .
Rovertis Pharmaceuticals Private Limited was incorporated on 04 Oct 2004.
The authorized share capital of Rovertis Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 0.96 M.
Currently 6 directors are associated with Rovertis Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Rovertis Pharmaceuticals Private Limited is 12-11-1427 Main Roadbowdhanagar Hyderabad, India, Andhra Pradesh, Telangana, 500061.
The corporate identification number (CIN) of Rovertis Pharmaceuticals Private Limited is U24239TG2004PTC044325 and the company number is 044325 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2016, the revenue trend for Rovertis Pharmaceuticals Private Limited has fallen by -5.75%.
The financial reports for the fiscal year 2016 indicates that The net worth of Rovertis Pharmaceuticals Private Limited has experienced an upsurge of 7.78%.
The most recent Balance Sheet for Rovertis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
GK
SR